Comprehensive Assessment of Hormonal Disruption in Primary Amenorrhea

Authors

  • Naheed Shah Department of Zoology, University of Sindh, Jamshoro, Pakistan Author
  • Samia Saliha Maryam Memorial Hospital, Rawalpindi, Pakistan Author
  • Sheeba Jan Department of Obstetrics and Gynecology, Kuwait Teaching Hospital, Peshawar, Pakistan Author
  • Zarina Naz National Institute of Medical Sciences, Rawalpindi, Pakistan Author
  • Zainab Tahir Sheikh Zayed Hospital, University of Health Sciences, Lahore, Pakistan Author
  • Hira Arshad Department of Obstetrics and Gynecology, Fouji Foundation Hospital, Rawalpindi, Pakistan Author

DOI:

https://doi.org/10.61919/pvdavs39

Keywords:

Primary amenorrhea; Estradiol; Follicle-stimulating hormone; Gonadotropins; Hypogonadism; Outflow tract anomalies; Ovarian disorders; Polycystic ovary syndrome

Abstract

Background: Primary amenorrhea is a heterogeneous condition reflecting disorders of hypothalamic–pituitary–ovarian function or reproductive tract development, and delayed presentation is common in resource-variable settings. Objective: To determine hormonal patterns and etiological distribution of primary amenorrhea among females presenting to tertiary care hospitals in South Punjab, Pakistan. Methods: This observational cross-sectional study enrolled 58 females with primary amenorrhea over two months. Clinical evaluation included demographics, BMI, Tanner breast staging, and pelvic ultrasonography. Serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, and thyroid-stimulating hormone (TSH) were measured using chemiluminescent immunoassays. Participants were stratified by FSH into hypogonadotropic (<3 mIU/mL), eugonadotropic (3–10 mIU/mL), and hypergonadotropic (>40 mIU/mL) categories. Etiology was determined using integrated clinical, biochemical, and imaging findings. Results: Mean age was 17.4 ± 2.1 years. Eugonadotropic amenorrhea was most common (44.8%), followed by hypogonadotropic (31.0%) and hypergonadotropic amenorrhea (24.1%). Outflow tract anomalies were the leading etiology (36.2%), followed by ovarian disorders (24.1%), hypothalamic–pituitary dysfunction (20.7%), and PCOS (12.1%). Eugonadotropic patients had the highest mean estradiol, while hypergonadotropic cases had markedly reduced estradiol. Conclusion: Structural and ovarian etiologies predominated, and hormonal stratification combined with ultrasonography supported pragmatic etiological triage and management planning.

References

1. Gaspari L, Paris F, Kalfa N, Sultan C. Primary amenorrhea in adolescents: approach to diagnosis and management. Endocrines. 2023;4(3):536–547.

2. Gaspari L, Paris F, Kalfa N, Sultan C. Primary amenorrhea in adolescents: approach to diagnosis and management. Endocrines. 2023;4:536–547.

3. Anthon C, Steinmann M, Vidal A, Dhakal C. Menstrual disorders in adolescence: diagnostic and therapeutic challenges. J Clin Med. 2024;13(24):7668.

4. Deo S, Singh S, Kumari P, Agarwal M, Ali W, Nigam N. Evaluation of etiopathology and management of primary and secondary amenorrhea in adolescent and young women in North Indian population. 2024.

5. Adão ML. Evaluation and management of primary amenorrhea. 2024.

6. Lewis V. Reproductive endocrinology and infertility. Boca Raton: CRC Press; 2024.

7. Christopoulos P, Vatopoulou A, Michala L, Nižňanská Z, Stankovic Z, Roos E, et al. Abstracts of the 16th European Congress of Paediatric and Adolescent Gynaecology. J Clin Med. 2024;13(24):7574.

8. Memi E, Pavli P, Papagianni M, Vrachnis N, Mastorakos G. Diagnostic and therapeutic use of oral micronized progesterone in endocrinology. Rev Endocr Metab Disord. 2024;25(4):751–772.

9. Ioannou D, Tempest HG. The genetic basis of male and female infertility. Semin Biol Reprod Med. 2025;71(1):143–169.

10. Zuhairi AK, Almomin AM, Alhubaish E, Mansour AA, Zuhairi AJ. The spectrum of hypogonadism in women from Basrah. Cureus. 2024;16(8).

11. Pan J, Liu P, Yu X, Zhang Z, Liu J. The adverse role of endocrine disrupting chemicals in the reproductive system. Front Endocrinol. 2024;14:1324993.

12. Ishii T, Kashimada K, Kawai M, Itonaga T, Iwasa T, Utsunomiya A, et al. Clinical practice guidelines for the management of differences of sex development in Japan. 2025.

13. Dashti Z, Falahi J, Parsanejad M. Reproductive genetics. Eur J Hum Genet. 2024;32:349–795.

14. Kalapahar S, Sharma S, Chattopadhyay R, Karan M. Overview of genetics in infertility. Bull Inst Reprod Med. 2024;39.

15. Van der Kelen A. The impact of genetics on reproductive medicine. 2024.

16. Mordovina II, Chebanu AK, Donnikov MY, Sinyukova TA, Kovalenko LV, Belotserkovtseva LD, et al. Genetic factors of reproductive disorders in female. 2024;8(03):186–195.

17. Khatun H, Halim T, Ferdous B, Rahman R, Hasan MM, Khan A. Prevalence of etiologic causes of primary amenorrhea among women in a tertiary care center. Sci Int J Obstet Gynecol. 2024;7(11):573–578.

18. Tiffany A. Exploring the heterogeneous genetic origin of female subfertility [thesis]. Ghent University; 2024.

19. Yalçın SFT. e-Posters EP01 cancer genetics. 2024.

20. Delcour C. Exploration des mécanismes étiopathogéniques des pathologies de la puberté [thesis]. Université Paris Cité; 2024.

Downloads

Published

2025-12-31

Issue

Section

Articles

How to Cite

Comprehensive Assessment of Hormonal Disruption in Primary Amenorrhea. (2025). Link Medical Journal, 3(2), 1-9. https://doi.org/10.61919/pvdavs39

Similar Articles

1-10 of 19

You may also start an advanced similarity search for this article.